Smart chemistry tackling complex biology

Drug Discovery Today: TARGETS

Volumn 1, Issue 3, 2002, Pages 81-82

  Sawyer, Tomi K ^a  

^a ARIAD PHARMACEUTICALS INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSE REDUCTASE INHIBITOR; BLOOD CLOTTING FACTOR 10A INHIBITOR; CATHEPSIN K INHIBITOR; PHOSPHOLIPASE A2 INHIBITOR; PHOSPHOTRANSFERASE INHIBITOR; PROTEIN INHIBITOR; PROTEINASE INHIBITOR; RENIN INHIBITOR; THROMBIN INHIBITOR; UNCLASSIFIED DRUG;

BIOLOGY; CHEMISTRY; COMBINATORIAL CHEMISTRY; DRUG DESIGN; DRUG EFFICACY; DRUG POTENCY; DRUG SCREENING; DRUG SELECTIVITY; DRUG STRUCTURE; DRUG TARGETING; EDITORIAL; GENETIC ANALYSIS; IMAGE ANALYSIS; MEDICINE; MOLECULAR BIOLOGY; MOLECULAR MODEL; MOLECULE; NUCLEAR MAGNETIC RESONANCE SPECTROSCOPY; PROBABILITY; PROTEOMICS; RISK ASSESSMENT; SIGNAL TRANSDUCTION; STRUCTURE ANALYSIS; TECHNOLOGY; THREE DIMENSIONAL IMAGING; X RAY CRYSTALLOGRAPHY;

EID: 0038533528     PISSN: 17418372     EISSN: None     Source Type: Journal    
DOI: 10.1016/s1477-3627(02)02203-1     Document Type: Editorial

References (28)

1. Klebe, G. (2000) Recent developments in structure-based drug design. J. Mol. Med. 78, 269-281
2. Gane, P.J. and Dean, P.M. (2000) Recent developments in rational structure-based drug design. Curr. Opin. Struct. Biol. 10, 401-404
3. Sawyer, T.K. (2001) Drug discovery in 3-D. Curr. Drug Discov. 6, 33-37
4. Mittl, P.R. and Grutter, M.G. (2001) Structural genomics: opportunities and challenges. Curr. Opin. Chem. Biol. 5, 402-408
5. Stevens, R.C. and Wilson, I.A. (2001) Industrializing structural biology. Science 293, 519-520
6. Russell, R.B. and Eggleston, D.S. (2000) New roles for structure in biology and drug discovery. Nat. Struct. Biol. 7 (Suppl.), 928-930
7. Hol, W.G. (2000) Structural genomics for science and society. Nat. Struct. Biol. 7 (Suppl.), 964-966
8. Nienaber, V.L. et al. (2000) Discovering novel ligands for macromolecules using X-ray crystallographic screening. Nat. Biotechnol. 18, 1105-1108
9. Blundell, T.L. et al. (2002) High-throughput crystallography for lead discovery in drug design. Nat. Rev. Drug Discov. 1, 45-54
10. Diercks, T. et al. (2001) Applications of NMR in drug discovery. Curr. Opin. Chem. Biol. 5, 285-291
11. Berman, H.M. et al. (2000) The Protein Data Bank. Nucleic Acids Res. 28, 235-242
12. Mason, J.S. et al. (2001) 3-D pharmacophores in drug discovery. Curr. Pharm. Des. 7, 567-597
13. Bajorath, J. (2002) Virtual screening: methods, expectations, and reality. Curr. Drug Discov. 2, 24-28
14. Abagyan, R. and Totrov, M. (2001) High-through put docking for lead generation. Curr. Opin. Chem. Biol. 5, 375-385
15. Olsson, T. and Oprea, T.I. (2001) Cheminformatics: a tool for decision-makers in drug discovery. Curr. Opin. Drug Discov. Devel. 4, 308-313
16. Ramstrom, O. and Lehn, J-M. (2002) Drug discovery by dynamic combinatorial libraries. Nat. Rev. Drug Discov. 1, 26-36
17. Agrafiotis, D.K. et al. (2002) Combinatorial informatics in the post-genomics era. Nat. Rev. Drug Discov. 1, 337-346
18. Bohm, H-J. and Stahl, M. (2000) Structure-based library design: molecular modeling merges with combinatorial chemistry. Curr. Opin. Chem. Biol. 4, 283-286
19. Golebiowski, A. et al. (2001) Lead compounds discovered from libraries. Curr. Opin. Chem. Biol. 5, 273-284
20. Schreiber, S.L. (2000) Target-oriented and diversity-oriented organic synthesis in drug discovery. Science 287, 1964-1969
21. Caron, P.R. et al. (2001) Chemogenomic approaches in drug discovery. Curr. Opin. Chem. Biol. 5, 464-470
22. Van de Waterbeemd, H. et al. (2001) Property-based design: optimization of drug absorption and pharmacokinetics. J. Med. Chem. 44, 1313-1333
23. Caldwell, G.W. et al. (2001) The new pre-clinical paradigm: compound optimization in early and late phase drug discovery. Curr. Topics Med. Chem. 1, 353-366
24. Lipinksi, C. et al. (1997) Experimental and computational approaches to estimate solubility and permeability in drug discovery and development settings. Adv. Drug Deliv. Rev. 23, 3-25
25. LaVan, D.A. et al. (2002) Moving smaller in drug discovery and delivery. Nat. Rev. Drug Discov. 1, 77-84
26. Gibbs, J.B. (2000) Mechanism-based target identification and drug discovery in cancer research. Science 287, 1969-1973
27. Drews, J. (2000) Drug discovery: a historical perspective. Science 287, 1960-1964
28. Hopkins, A.L. and Groom, C.R. (2002) The druggable genome. Nat. Rev. Drug Discov. 1, 727-730